EWA
VYGR icon

EverSource Wealth Advisors’s Voyager Therapeutics VYGR Stock Holding History

EverSource Wealth Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39K Buy
683
+262
+62% +$994 ﹤0.01% 3654
2026
Q1 		$1.63K Buy
421
+136
+48% +$535 ﹤0.01% 3705
2025
Q4 		$1.12K Hold
285
– – ﹤0.01% 3675
2025
Q3 		$1.33K Buy
285
+83
+41% +$300 ﹤0.01% 3661
2025
Q2 		$629 Buy
202
+47
+30% +$152 ﹤0.01% 3843
2025
Q1 		$523 Buy
+155
New +$724 ﹤0.01% 3445

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EverSource Wealth Advisors's VYGR Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Voyager Therapeutics (VYGR) stake by 62% in Q2 2026, buying an estimated $994 and bringing the position to 683 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #3654.

EverSource Wealth Advisors first reported a position in VYGR in Q1 2025 and has held it in 6 quarters since. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • EverSource Wealth Advisors held 683 shares of Voyager Therapeutics worth $2.39K as of Q2 2026.
  • EverSource Wealth Advisors bought 262 Voyager Therapeutics shares in Q2 2026, an estimated $994.
  • Voyager Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3654 holding.
  • EverSource Wealth Advisors first reported a position in Voyager Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.